Selected Publications
1. Babalola, YO. (2020). Preoperative Evaluation Of Patients For Scleral Buckling Surgery. In Step By Step Scleral Buckling Surgery. Oluleye TS, Babalola YO., Majekodunmi O, Ijaduola M. and Sarimiye T. Book builders(Eds). Nigeria.
2. Ogun OA, Babalola YO. (2023). Ocular involvement in Systemic Diseases. In Essentials of Ophthalmology in the Tropics. Editors - Bekibele CO, Oluleye TS, Ogun OA, Abdul MM, Onakpoya O, Imoro B, Akafo S, Edema O, Osaguona VB, Kyari F. Stirling Horden Publishers Limited, Ibadan, Nigeria
3. Babalola YO. Anterior Segment and Ocular Adnexal Lesions in Patients with Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome at a Tertiary Hospital in Southwestern Nigeria. Niger J Med 2023; 32(1):63-68.
4. Babalola YO, Shah M, Padhy SK, Behera UC. Bilateral astrocytic hamartoma with vasoproliferative tumour in retinitis pigmentosa. Niger Postgrad Med J 2023;30:81-4.
5. Babalola YO. Learning points from selected cases of scleral buckling surgery for rhegmatogenous retinal detachments. Niger J Vitreoretin Dis 2022;5:54-65.
6. Babalola YO, Ibiyemi AA, Oluseye MO. X-linked Juvenile retinoschisis presenting with rhegmatogenous retinal detachment in a male Nigerian adolescent: A case report. Niger Postgrad Med J. 2022;29:278-80.
7. Babalola YO. Coloboma of the retina, choroid and iris co-existing with cardiac & Skeletal anomalies in a male Nigerian: A case of Noonan syndrome. Niger J Clin Pract 2022;25: 1377-81.
8. Babalola YO, Oluleye TS, Ashaye AO. Vitreoretinal manifestations of human immunodeficiency virus infection and acquired immunodeficiency syndrome in patients attending an antiretroviral therapy clinic in Nigeria: A cross sectional study. J Clin Sci 2022;19:7 3-9.
9. Megbelayin EO, Babalola YO, Nkanga Dennis E. Ocular B-scan audit in a sub-Saharan African retina facility. Nigerian Journal of Vitreoretinal Diseases NJVRD 2021;(4) 1:11-16
10. Oluleye TS, Babalola YO, Majekodunmi OI, Ijaduola MA. Sickle cell retinopathy: Patient awareness, mode of presentation and treatment modalities in Ibadan, South-Western, Nigeria. Niger J Med 2021;30:481-6
11. Babalola YO. Macula hole as a sequelae of presumed ocular toxoplasmosis, an incidental finding in a female Nigerian: Case report and review of literature. Niger J Clin Pract 2021;24:959-63
12. Babalola YO, Baiyeroju AM. Optic disc drusen and a constellation of other features of Retinitis pigmentosa: A Case report. International Journal of Ophthalmology & Visual Science. Int J Ophthal & Vis Sci 2021;(6) 1:63-66
13. Oluleye TS, Babalola YO, Majekodunmi OI, Ijaduola MA, Adewole TA. Visual outcomes of Anti-vascular Endothelial growth factor injections at the University College hospital, Ibadan. Ann Afr Med. 2021 Oct-Dec; 20(4): 276–281.
14. Oluleye TS, Babalola YO, Majekodunmi OI, Ijaduola MA. Macula diseases in Ibadan. Niger J Clin Pract 2021; 24:341-4
15. Babalola YO, Oluleye TS, Majekodunmi O, Ijaduola M. Intravitreal anti-vascular endothelial growth factor (anti-VEGF) for retinopathy of prematurity in Ibadan: Method of administration. Niger J. Med. 2020. 29(3): 37:460-465
16. Oluleye TS, Babalola YO, Olusanya BA, Majekodunmi O, Ijaduola M: Learning styles of fresh clinical students in Ophthalmology at the University of Ibadan, Nigeria – A pilot study. Niger J. Med 2020. 29 (3):377- 383
17. Taleb EA, Nagpal MP, Mehrotra NS, Bhatt K, Goswami S, Babalola YO, Nomam A: Comparison of clinical outcome between 23G and 25 G vitrectomy in diabetic patients. Oman J Ophthalmol 2017; 10:213-9
18. Oluleye TS, Babalola YO, Ijaduola M: Chloroquin retinopathy: Pattern of presentation in Ibadan, Sub-saharan Africa. Eye 2016; Jan 2; 30 (1):64-7
19. Oluleye TS, Babalola YO. Indications for intravitreal bevacizumab in Ibadan, Sub-saharan Africa. The Open Ophthalmology Journal 2014; vol 8:87-90
20. Oluleye TS; Babalola YO. Pattern of Idiopathic choroidal polypoidal vasculopathy in Ibadan, Sub-saharan, Africa. Clinical Ophthalmology (Auckland NZ) 07/2013;7: 1376-8